The smart infusion pumps market size has grown strongly in recent years. It will grow from $8.88 billion in 2025 to $9.73 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to reliance on standard infusion pumps, limited integration with hospital IT systems, growing oncology and pediatric patient base, increasing hospital and clinic infrastructure, adoption of single-channel volumetric pumps.
The smart infusion pumps market size is expected to see strong growth in the next few years. It will grow to $13.84 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to development of multi-channel and programmable infusion systems, integration with electronic medical records (EMR), rising demand for home care infusion therapies, adoption of MRI-compatible and wireless infusion pumps, increasing use of digital and smart pump technologies. Major trends in the forecast period include rising adoption of smart pump technology, integration of wireless and closed-loop infusion systems, increasing use in home care and ambulatory settings, focus on reducing medication errors and enhancing patient safety, expansion of infusion pumps in specialty clinics and oncology.
The rise in chronic diseases is expected to drive the growth of the smart infusion pumps market in the coming years. Chronic diseases are long-term conditions that develop over time and typically require ongoing care or management. The growing prevalence of such conditions is largely attributed to increasingly sedentary lifestyles, which contribute to obesity, diabetes, and cardiovascular disorders. Smart infusion pumps play a critical role in managing chronic diseases by delivering precise and automated doses of medication, thereby reducing human error and improving long-term treatment outcomes. For example, in April 2025, the International Diabetes Federation (IDF), a Belgium-based non-profit organization, reported that nearly 589 million adults aged 20-79 are living with diabetes worldwide, a figure projected to increase significantly to 853 million by 2050. This rising incidence of chronic disease is thus fueling the demand for smart infusion pumps.
Companies operating in the smart infusion pumps market are prioritizing innovation, particularly through the development of cassette-based infusion pumps that aim to enhance medication delivery accuracy, improve patient safety, and streamline clinical workflows. Cassette-based infusion pumps use disposable cassettes to administer fluids or medications with high precision. For instance, in August 2023, ICU Medical Inc., a U.S.-based medical technology company, received 510(k) regulatory clearance from the U.S. Food and Drug Administration (FDA) for its Plum Duo infusion pump, which is integrated with the cloud-based LifeShield software. The pump features dual-channel delivery for simultaneous administration of two compatible intravenous therapies, thereby improving workflow efficiency and patient care. It also incorporates advanced drug library integration and automated programming to minimize medication errors. The LifeShield software enhances the pump with real-time monitoring, data-driven insights, and clinical decision support, which together ensure higher infusion safety and adherence to hospital protocols.
In September 2023, Abbott Laboratories, a U.S.-based pharmaceutical company, acquired Bigfoot Biomedical for an undisclosed sum. This acquisition is intended to strengthen Abbott’s diabetes care offerings by integrating Bigfoot Biomedical’s smart insulin management technology with its FreeStyle Libre continuous glucose monitoring system. This integration aims to deliver a more comprehensive and connected solution for patients who require insulin. Bigfoot Biomedical Inc. is a U.S.-based company specializing in the development of smart infusion pumps.
Major companies operating in the smart infusion pumps market are Fresenius Kabi AG, Medtronic plc, Becton Dickinson and Company, Baxter International Inc, Terumo Corporation, Mindray Medical International Limited, Moog Inc, ICU Medical Inc, Insulet Corporation, Avanos Medical Inc, JMS Co Ltd, Vygon SA, B Braun Melsungen AG, Eitan Group, Heka Healthcare B V, PROMECON GmbH, Micrel Medical Devices SA, Smiths Medical, Zyno Medical LLC, CME Medical, Bionical Emas, Nipro Corporation.
North America was the largest region in the smart infusion pumps market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the smart infusion pumps market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the smart infusion pumps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the smart infusion pumps market by increasing the cost of imported electronic components, sensors, and smart pump modules. Segments like digital infusion systems, wireless infusion pumps, and MRI-compatible pumps are particularly affected, with Asia-Pacific regions such as China and India seeing higher import duties. This has led to increased production costs and potential delays in deployment. On the positive side, tariffs encourage local manufacturing, investment in domestic supply chains, and innovation in cost-effective smart pump solutions.
The smart infusion pumps market research report is one of a series of new reports that provides smart infusion pumps market statistics, including smart infusion pumps industry global market size, regional shares, competitors with a smart infusion pumps market share, detailed smart infusion pumps market segments, market trends and opportunities, and any further data you may need to thrive in the smart infusion pumps industry. This smart infusion pumps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Smart infusion pumps are sophisticated upgrades of conventional infusion pumps, equipped with software and sometimes integrated connectivity features aimed at improving the safety and efficiency of medication administration. These devices come with advanced functionalities such as drug libraries, alert systems, and other intelligent technologies that help minimize human errors and enhance the precision of drug delivery.
The primary categories of smart infusion pumps include large volumetric infusion pumps, patient-controlled analgesia pumps, syringe infusion systems, electronic ambulatory infusion systems, implantable infusion systems, MRI-compatible IV infusion pump systems, disposable elastomeric infusion systems, and others. Among these, large volumetric infusion pumps are specifically engineered to administer high volumes of fluids, medications, or nutrients into the patient’s bloodstream at regulated flow rates. These devices utilize various technologies such as digital infusion systems, smart pump platforms, wireless connectivity, traditional infusion mechanisms, and closed-loop controls. They are widely used across multiple medical disciplines such as oncology or chemotherapy, pediatrics or neonatology, gastroenterology, hematology, diabetes care, and others, and are employed in diverse healthcare environments, including hospitals, ambulatory surgical centers, home healthcare, specialty clinics, and more.
The smart infusion pumps market includes revenues earned by entities by providing services such as equipment installation, maintenance, software updates, user training, and technical support. The market value includes the value of related goods sold by the service provider or included within the service offering. The smart infusion pumps market also includes sales of infusion pump units, syringes, pole clamps, and mounting hardware. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The smart infusion pumps market size is expected to see strong growth in the next few years. It will grow to $13.84 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to development of multi-channel and programmable infusion systems, integration with electronic medical records (EMR), rising demand for home care infusion therapies, adoption of MRI-compatible and wireless infusion pumps, increasing use of digital and smart pump technologies. Major trends in the forecast period include rising adoption of smart pump technology, integration of wireless and closed-loop infusion systems, increasing use in home care and ambulatory settings, focus on reducing medication errors and enhancing patient safety, expansion of infusion pumps in specialty clinics and oncology.
The rise in chronic diseases is expected to drive the growth of the smart infusion pumps market in the coming years. Chronic diseases are long-term conditions that develop over time and typically require ongoing care or management. The growing prevalence of such conditions is largely attributed to increasingly sedentary lifestyles, which contribute to obesity, diabetes, and cardiovascular disorders. Smart infusion pumps play a critical role in managing chronic diseases by delivering precise and automated doses of medication, thereby reducing human error and improving long-term treatment outcomes. For example, in April 2025, the International Diabetes Federation (IDF), a Belgium-based non-profit organization, reported that nearly 589 million adults aged 20-79 are living with diabetes worldwide, a figure projected to increase significantly to 853 million by 2050. This rising incidence of chronic disease is thus fueling the demand for smart infusion pumps.
Companies operating in the smart infusion pumps market are prioritizing innovation, particularly through the development of cassette-based infusion pumps that aim to enhance medication delivery accuracy, improve patient safety, and streamline clinical workflows. Cassette-based infusion pumps use disposable cassettes to administer fluids or medications with high precision. For instance, in August 2023, ICU Medical Inc., a U.S.-based medical technology company, received 510(k) regulatory clearance from the U.S. Food and Drug Administration (FDA) for its Plum Duo infusion pump, which is integrated with the cloud-based LifeShield software. The pump features dual-channel delivery for simultaneous administration of two compatible intravenous therapies, thereby improving workflow efficiency and patient care. It also incorporates advanced drug library integration and automated programming to minimize medication errors. The LifeShield software enhances the pump with real-time monitoring, data-driven insights, and clinical decision support, which together ensure higher infusion safety and adherence to hospital protocols.
In September 2023, Abbott Laboratories, a U.S.-based pharmaceutical company, acquired Bigfoot Biomedical for an undisclosed sum. This acquisition is intended to strengthen Abbott’s diabetes care offerings by integrating Bigfoot Biomedical’s smart insulin management technology with its FreeStyle Libre continuous glucose monitoring system. This integration aims to deliver a more comprehensive and connected solution for patients who require insulin. Bigfoot Biomedical Inc. is a U.S.-based company specializing in the development of smart infusion pumps.
Major companies operating in the smart infusion pumps market are Fresenius Kabi AG, Medtronic plc, Becton Dickinson and Company, Baxter International Inc, Terumo Corporation, Mindray Medical International Limited, Moog Inc, ICU Medical Inc, Insulet Corporation, Avanos Medical Inc, JMS Co Ltd, Vygon SA, B Braun Melsungen AG, Eitan Group, Heka Healthcare B V, PROMECON GmbH, Micrel Medical Devices SA, Smiths Medical, Zyno Medical LLC, CME Medical, Bionical Emas, Nipro Corporation.
North America was the largest region in the smart infusion pumps market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the smart infusion pumps market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the smart infusion pumps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the smart infusion pumps market by increasing the cost of imported electronic components, sensors, and smart pump modules. Segments like digital infusion systems, wireless infusion pumps, and MRI-compatible pumps are particularly affected, with Asia-Pacific regions such as China and India seeing higher import duties. This has led to increased production costs and potential delays in deployment. On the positive side, tariffs encourage local manufacturing, investment in domestic supply chains, and innovation in cost-effective smart pump solutions.
The smart infusion pumps market research report is one of a series of new reports that provides smart infusion pumps market statistics, including smart infusion pumps industry global market size, regional shares, competitors with a smart infusion pumps market share, detailed smart infusion pumps market segments, market trends and opportunities, and any further data you may need to thrive in the smart infusion pumps industry. This smart infusion pumps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Smart infusion pumps are sophisticated upgrades of conventional infusion pumps, equipped with software and sometimes integrated connectivity features aimed at improving the safety and efficiency of medication administration. These devices come with advanced functionalities such as drug libraries, alert systems, and other intelligent technologies that help minimize human errors and enhance the precision of drug delivery.
The primary categories of smart infusion pumps include large volumetric infusion pumps, patient-controlled analgesia pumps, syringe infusion systems, electronic ambulatory infusion systems, implantable infusion systems, MRI-compatible IV infusion pump systems, disposable elastomeric infusion systems, and others. Among these, large volumetric infusion pumps are specifically engineered to administer high volumes of fluids, medications, or nutrients into the patient’s bloodstream at regulated flow rates. These devices utilize various technologies such as digital infusion systems, smart pump platforms, wireless connectivity, traditional infusion mechanisms, and closed-loop controls. They are widely used across multiple medical disciplines such as oncology or chemotherapy, pediatrics or neonatology, gastroenterology, hematology, diabetes care, and others, and are employed in diverse healthcare environments, including hospitals, ambulatory surgical centers, home healthcare, specialty clinics, and more.
The smart infusion pumps market includes revenues earned by entities by providing services such as equipment installation, maintenance, software updates, user training, and technical support. The market value includes the value of related goods sold by the service provider or included within the service offering. The smart infusion pumps market also includes sales of infusion pump units, syringes, pole clamps, and mounting hardware. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Smart Infusion Pumps Market Characteristics
3. Smart Infusion Pumps Market Supply Chain Analysis
4. Global Smart Infusion Pumps Market Trends and Strategies
5. Smart Infusion Pumps Market Analysis of End Use Industries
7. Global Smart Infusion Pumps Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Smart Infusion Pumps Total Addressable Market (TAM) Analysis for the Market
9. Smart Infusion Pumps Market Segmentation
10. Smart Infusion Pumps Market Regional and Country Analysis
11. Asia-Pacific Smart Infusion Pumps Market
12. China Smart Infusion Pumps Market
13. India Smart Infusion Pumps Market
14. Japan Smart Infusion Pumps Market
15. Australia Smart Infusion Pumps Market
16. Indonesia Smart Infusion Pumps Market
17. South Korea Smart Infusion Pumps Market
18. Taiwan Smart Infusion Pumps Market
19. South East Asia Smart Infusion Pumps Market
20. Western Europe Smart Infusion Pumps Market
21. UK Smart Infusion Pumps Market
22. Germany Smart Infusion Pumps Market
23. France Smart Infusion Pumps Market
24. Italy Smart Infusion Pumps Market
25. Spain Smart Infusion Pumps Market
26. Eastern Europe Smart Infusion Pumps Market
27. Russia Smart Infusion Pumps Market
28. North America Smart Infusion Pumps Market
29. USA Smart Infusion Pumps Market
30. Canada Smart Infusion Pumps Market
31. South America Smart Infusion Pumps Market
32. Brazil Smart Infusion Pumps Market
33. Middle East Smart Infusion Pumps Market
34. Africa Smart Infusion Pumps Market
36. Smart Infusion Pumps Market Competitive Landscape and Company Profiles
37. Smart Infusion Pumps Market Other Major and Innovative Companies
40. Smart Infusion Pumps Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Smart Infusion Pumps Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses smart infusion pumps market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for smart infusion pumps? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The smart infusion pumps market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Large Volumetric Infusion Pumps; Patient Controlled Analgesia Pumps; Syringe Infusion Systems; Electronic- Ambulatory Infusion Systems; Implantable Infusion Systems; MRI-Compatible IV Infusion Pump Systems; Disposable Elastomeric Infusion Systems; Other Types2) By Technology: Smart Pump Technology; Digital Infusion Systems; Wireless Infusion Systems; Standard Infusion Pumps; Closed-Loop Systems
3) By Application: Chemotherapy Or Oncology; Pediatrics Or Neonatology; Gastroenterology; Hematology; Diabetes; Other Applications
4) By End User: Hospitals; Ambulatory Surgical Centers; Home Care; Specialty Clinics; Other End User
Subsegments:
1) By Large Volumetric Infusion Pumps: Single Channel Pumps; Multi-Channel Pumps; Stand-Alone Systems; Integrated Systems2) By Patient Controlled Analgesia (PCA) Pumps: Disposable PCA Pumps; Electronic PCA Pumps
3) By Syringe Infusion Systems: Motor-Driven Syringe Systems; Spring-Driven Syringe Systems
4) By Electronic-Ambulatory Infusion Systems: Programmable Ambulatory Pumps; Non-Programmable Ambulatory Pumps
5) By Implantable Infusion Systems: Intrathecal Drug Delivery Pumps; Insulin Delivery Pumps
6) By MRI-Compatible IV Infusion Pump Systems: Shielded MRI-Compatible Pumps; Non-Shielded MRI-Compatible Pumps
7) By Disposable Elastomeric Infusion Systems: Continuous Flow Pumps; Patient-Controlled Flow Pumps
8) By Other Types: Enteral Feeding Pumps; Insulin Infusion Pumps; Chemotherapy Infusion Pumps
Companies Mentioned: Fresenius Kabi AG; Medtronic plc; Becton Dickinson and Company; Baxter International Inc; Terumo Corporation; Mindray Medical International Limited; Moog Inc; ICU Medical Inc; Insulet Corporation; Avanos Medical Inc; JMS Co Ltd; Vygon SA; B Braun Melsungen AG; Eitan Group; Heka Healthcare B V; PROMECON GmbH; Micrel Medical Devices SA; Smiths Medical; Zyno Medical LLC; CME Medical; Bionical Emas; Nipro Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Smart Infusion Pumps market report include:- Fresenius Kabi AG
- Medtronic plc
- Becton Dickinson and Company
- Baxter International Inc
- Terumo Corporation
- Mindray Medical International Limited
- Moog Inc
- ICU Medical Inc
- Insulet Corporation
- Avanos Medical Inc
- JMS Co Ltd
- Vygon SA
- B Braun Melsungen AG
- Eitan Group
- Heka Healthcare B V
- PROMECON GmbH
- Micrel Medical Devices SA
- Smiths Medical
- Zyno Medical LLC
- CME Medical
- Bionical Emas
- Nipro Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 9.73 Billion |
| Forecasted Market Value ( USD | $ 13.84 Billion |
| Compound Annual Growth Rate | 9.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
